Yes , I think the QIDP designation is suppose to speed up the process of getting the antibiotic to market although as James mentions it also gets 10 years exclusivity which is what James likes most .
Maybe they should just market their antibiotics directly to the veterinarian market , James does not come across as having much personality when he speaks with his monotone voice ie boring .
Ann: Recce Presented at FNN/Shaw and Partners Investor Conference, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.0¢ |
Change
0.005(0.93%) |
Mkt cap ! $125.2M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 55.0¢ | 51.5¢ | $55.38K | 104.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 455 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 50720 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |